BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 15754155)

  • 1. Role of endothelial dysfunction and insulin resistance in angina pectoris and normal coronary angiogram.
    Monti LD; Piatti PM
    Herz; 2005 Feb; 30(1):48-54. PubMed ID: 15754155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of coronary blood flow during exercise.
    Duncker DJ; Bache RJ
    Physiol Rev; 2008 Jul; 88(3):1009-86. PubMed ID: 18626066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exercise tolerance and hyperinsulinemia in cardiac syndrome X.
    Kolasilska-Kloch W; Leśniak W; Leszczyńska-Gołabek I; Kieć-Wilk B; Kloch M
    Folia Med Cracov; 2004; 45(1-2):13-23. PubMed ID: 16276822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin resistance and endothelial dysfunction: the road map to cardiovascular diseases.
    Cersosimo E; DeFronzo RA
    Diabetes Metab Res Rev; 2006; 22(6):423-36. PubMed ID: 16506274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelial and metabolic characteristics of patients with angina and angiographically normal coronary arteries: comparison with subjects with insulin resistance syndrome and normal controls.
    Piatti P; Fragasso G; Monti LD; Caumo A; Van Phan C; Valsecchi G; Costa S; Fochesato E; Pozza G; Pontiroli AE; Chierchia S
    J Am Coll Cardiol; 1999 Nov; 34(5):1452-60. PubMed ID: 10551692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of simvastatin on the reserve of heart function and endothelial function in X-syndrome].
    Xie XW; Zhuang HP; Tang FY; Yao JM
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Aug; 33(8):700-4. PubMed ID: 18772509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The role and clinical importance of nitric oxide-endothelin system in hypertension].
    Katona E; Juhász M; Varga Z; Paragh G; Fülesdi B; Páll D
    Orv Hetil; 2006 Sep; 147(38):1819-24. PubMed ID: 17066598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic development in cardiac syndrome X: a need to target the underlying pathophysiology.
    Lim TK; Choy AJ; Khan F; Belch JJ; Struthers AD; Lang CC
    Cardiovasc Ther; 2009; 27(1):49-58. PubMed ID: 19207480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac syndrome X.
    Asbury EA; Collins P
    Int J Clin Pract; 2005 Sep; 59(9):1063-9. PubMed ID: 16115183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [HIV infection, antiretroviral therapy, and endothelium].
    Hürlimann D; Weber R; Enseleit F; Lüscher TF
    Herz; 2005 Sep; 30(6):472-80. PubMed ID: 16170677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Microvascular angina and syndrome X].
    Kaski JC; Pérez Fernández R
    Rev Esp Cardiol; 2002; 55 Suppl 1():10-6. PubMed ID: 15626351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin resistance, metabolic syndrome and vascular diseases: update on mechanistic linkages.
    Lteif A; Mather K
    Can J Cardiol; 2004 Aug; 20 Suppl B():66B-76B. PubMed ID: 15309208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac syndrome X and endothelial dysfunction: new concepts in prognosis and treatment.
    Hurst T; Olson TH; Olson LE; Appleton CP
    Am J Med; 2006 Jul; 119(7):560-6. PubMed ID: 16828624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin resistance, hyperleptinemia and endothelial dysfunction in coronary restenosis.
    Piatti P; Monti LD
    Curr Opin Pharmacol; 2005 Apr; 5(2):160-4. PubMed ID: 15780825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coronary circulatory dysfunction in insulin resistance, impaired glucose tolerance, and type 2 diabetes mellitus.
    Prior JO; Quiñones MJ; Hernandez-Pampaloni M; Facta AD; Schindler TH; Sayre JW; Hsueh WA; Schelbert HR
    Circulation; 2005 May; 111(18):2291-8. PubMed ID: 15851590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammation and endothelial dysfunction as therapeutic targets in patients with heart failure.
    Tousoulis D; Charakida M; Stefanadis C
    Int J Cardiol; 2005 Apr; 100(3):347-53. PubMed ID: 15837076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of nitric oxide-producing and -degrading pathways in coronary endothelial dysfunction in chronic kidney disease.
    Tatematsu S; Wakino S; Kanda T; Homma K; Yoshioka K; Hasegawa K; Sugano N; Kimoto M; Saruta T; Hayashi K
    J Am Soc Nephrol; 2007 Mar; 18(3):741-9. PubMed ID: 17267746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between insulin resistance and endothelial dysfunction in renal transplant recipients.
    Voytovich MH; Asberg A; Hjelmesaeth J; Jenssen T; Hartmann A
    Clin Transplant; 2006; 20(2):195-9. PubMed ID: 16640526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of coronary dysfunction in obesity and insulin resistance.
    Knudson JD; Dincer UD; Bratz IN; Sturek M; Dick GM; Tune JD
    Microcirculation; 2007; 14(4-5):317-38. PubMed ID: 17613805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated circulating inflammatory markers in female patients with cardiac syndrome X.
    Li JJ; Zhu CG; Nan JL; Li J; Li ZC; Zeng HS; Gao Z; Qin XW; Zhang CY
    Cytokine; 2007 Dec; 40(3):172-6. PubMed ID: 17945505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.